Unleashing the potential of extracellular vesicles for ulcerative colitis and Crohn's disease therapy
Inflammatory bowel disorders (IBD), comprising Crohn's disease (CD) and ulcerative colitis (UC), are chronic inflammatory conditions of the gastrointestinal tract (GIT). They pose significant treatment challenges due to their complex etiology. Current therapies focus on reducing inflammation bu...
Saved in:
Main Authors: | George Chigozie Njoku, Cathal Patrick Forkan, Fumie Mitani Soltysik, Peter Lindberg Nejsum, Flemming Pociot, Reza Yarani |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2025-03-01
|
Series: | Bioactive Materials |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2452199X24004882 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Could hypoxic conditioning augment the potential of mesenchymal stromal cell-derived extracellular vesicles as a treatment for type 1 diabetes?
by: Cathal Patrick Forkan, et al.
Published: (2025-02-01) -
Cucurbitacin IIa Alleviates Colitis via Promoting the Release of Host-Derived Extracellular Vesicles Encapsulating microRNA-30b-5p
by: Zhao Y, et al.
Published: (2025-01-01) -
Multi-omics unveils strain-specific neuroactive metabolite production linked to inflammation modulation by Bacteroides and their extracellular vesicles
by: Basit Yousuf, et al.
Published: (2025-01-01) -
PMA1-containing extracellular vesicles of Candida albicans triggers immune responses and colitis progression
by: Zhen Xu, et al.
Published: (2025-12-01) -
Epidemiology and Treatment Patterns of Fistulizing Crohn’s Disease in a Large, Real-World Australasian Cohort
by: Jack McNamara, et al.
Published: (2025-01-01)